(PR-inside.com) FORT LAUDERDALE, MIAMI -- (Marketwire) -- 05/03/11 -- Exciting results from the Argus™ II Retinal Prosthesis System ('Argus II') clinical trial were presented today at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2011 Annual Meeting. The clinical trial included 30 subjects implanted in 10 centers worldwide, and has run for nearly 4 years. The results that were presented from the trial showed that the Argus II System provided significant improvements in vision for the blind subjects who are suffering from profound Retinitis Pigmentosa (RP). Two paper presentations outlined the safety, reliability and performance of the system. ..
More...
More...